Skip to main content
Top
Published in: Abdominal Radiology 8/2021

01-08-2021 | Prostate Cancer | Pelvis

The absolute tumor-capsule contact length in the diagnosis of extraprostatic extension of prostate cancer

Authors: Kulyada Eurboonyanun, Nisanard Pisuchpen, Aileen O’Shea, Rita Maria Lahoud, Isha D. Atre, Mukesh Harisinghani

Published in: Abdominal Radiology | Issue 8/2021

Login to get access

Abstract

Background

Extraprostatic extension (EPE) of prostate cancer is associated with a poor prognosis. The broad-based capsule-tumor interface has been recognized as one of the worrisome imaging features in multiparametric prostate MRI (mpMRI). However, there was significant heterogeneity among the measurement method used in prior studies.

Objectives

This study’s objectives were to investigate and compare the accuracy between the curvilinear and linear measurement, find the optimal cut-off contact surface threshold for the diagnosis of EPE, and assess the benefit of the additional contact surface measurement versus visual assessment alone.

Methods

The status of EPE in mpMRI and the overall PI-RADS were assessed. The tumor’s dimensions, the actual tumor-capsule contact length (ACTCL), and the absolute tumor-capsule contact length (ABTCL) were measured. The parameters were analyzed and correlated with the EPE status from prostatectomy specimens.

Results

Ninety-five patients who underwent mpMRI followed by prostatectomy were included in the study. High Gleason score (score 8–9), radiologist’s impression of EPE, and PI-RADS 5 were significantly correlated with EPE in surgical specimens (p = 0.014, p < 0.001, and p < 0.001, respectively). Both ACTCL and ABTCL of patients with EPE were significantly higher than those without EPE in all imaging sequences (p < 0.001 to p = 0.003). The ABTCL has higher accuracy than the ACTCL. Dynamic contrast enhancement (DCE) was the most accurate sequence to measure the contact interface. The recommended cut-off value of ABTCL was 15.0 mm, which had a sensitivity and specificity of 75.86% and 72.09%. Multivariable analysis revealed that the ABTCL > 15 mm and the radiologist’s impression on visual assessment were the only two independent predictors for the prediction of EPE (p = 0.048 and p = 0.016, respectively). Improvement of diagnostic performance was achieved when the two factors were combined.

Conclusion

The ABTCL has better accuracy than the curvilinear measurement in the prediction of EPE. The optimum sequence for the measurement of the contact surface is the DCE. We recommended using 15.0 mm as a cut-off point.

Clinical impact

The addition of the ABTCL measurement showed an increase in diagnostic performance. We encourage radiologists to use the capsular contact measurement in addition to their visual assessment to detect EPE in pre-operative MRI.
Literature
2.
go back to reference Buyyounouski MK, Choyke PL, McKenney JK, et al (2017) Prostate Cancer – Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin 67:245–253. https://doi.org/https://doi.org/10.3322/caac.21391 Buyyounouski MK, Choyke PL, McKenney JK, et al (2017) Prostate Cancer – Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin 67:245–253. https://​doi.​org/​https://​doi.​org/​10.​3322/​caac.​21391
7.
go back to reference Keyes M, Crook J, Morton G, et al (2013) Treatment options for localized prostate cancer. Can Fam Physician 59:1269–1274PubMedPubMedCentral Keyes M, Crook J, Morton G, et al (2013) Treatment options for localized prostate cancer. Can Fam Physician 59:1269–1274PubMedPubMedCentral
12.
go back to reference Boesen L (2017) Multiparametric MRI in detection and staging of prostate cancer. Dan Med J 64:B5327.PubMed Boesen L (2017) Multiparametric MRI in detection and staging of prostate cancer. Dan Med J 64:B5327.PubMed
14.
go back to reference Schoots IG, Roobol MJ, Nieboer D, et al (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438–450. https://doi.org/https://doi.org/10.1016/j.eururo.2014.11.037CrossRefPubMed Schoots IG, Roobol MJ, Nieboer D, et al (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438–450. https://​doi.​org/​https://​doi.​org/​10.​1016/​j.​eururo.​2014.​11.​037CrossRefPubMed
24.
go back to reference Bakir B, Onay A, Vural M, et al (2019) Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups. American Journal of Roentgenology 214:588–596. https://doi.org/https://doi.org/10.2214/AJR.19.21828CrossRefPubMed Bakir B, Onay A, Vural M, et al (2019) Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups. American Journal of Roentgenology 214:588–596. https://​doi.​org/​https://​doi.​org/​10.​2214/​AJR.​19.​21828CrossRefPubMed
38.
go back to reference Rud E, Diep L, Baco E (2018) A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient. World J Urol 36:629–637. https://doi.org/https://doi.org/10.1007/s00345-018-2171-4CrossRefPubMed Rud E, Diep L, Baco E (2018) A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient. World J Urol 36:629–637. https://​doi.​org/​https://​doi.​org/​10.​1007/​s00345-018-2171-4CrossRefPubMed
Metadata
Title
The absolute tumor-capsule contact length in the diagnosis of extraprostatic extension of prostate cancer
Authors
Kulyada Eurboonyanun
Nisanard Pisuchpen
Aileen O’Shea
Rita Maria Lahoud
Isha D. Atre
Mukesh Harisinghani
Publication date
01-08-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03063-2

Other articles of this Issue 8/2021

Abdominal Radiology 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.